Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.95 TWD
−1.16 B TWD
389.62 M TWD
238.93 M
About MEDIGEN VACCINE BIOLOGICS CORPORATE
Sector
Industry
CEO
Tsan Jian Chen
Website
Headquarters
Zhubei
Founded
2012
ISIN
TW0006547003
FIGI
BBG009PX9G96
Medigen Vaccine Biologics Corp. engages in the research, development, and wholesale of vaccine and biopharmaceutical, and wholesale and retail of medical devices. The company was founded on October 12, 2012 and is headquartered in Zhubei, Taiwan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6547 is 37.05 TWD — it has increased by 3.98% in the past 24 hours. Watch MEDIGEN VACCINE BIOLOGICS CORPORATE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange MEDIGEN VACCINE BIOLOGICS CORPORATE stocks are traded under the ticker 6547.
6547 stock has risen by 6.56% compared to the previous week, the month change is a −3.31% fall, over the last year MEDIGEN VACCINE BIOLOGICS CORPORATE has showed a −46.77% decrease.
We've gathered analysts' opinions on MEDIGEN VACCINE BIOLOGICS CORPORATE future price: according to them, 6547 price has a max estimate of 102.00 TWD and a min estimate of 102.00 TWD. Watch 6547 chart and read a more detailed MEDIGEN VACCINE BIOLOGICS CORPORATE stock forecast: see what analysts think of MEDIGEN VACCINE BIOLOGICS CORPORATE and suggest that you do with its stocks.
6547 reached its all-time high on May 17, 2021 with the price of 280.20 TWD, and its all-time low was 15.15 TWD and was reached on Aug 24, 2015. View more price dynamics on 6547 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6547 stock is 5.34% volatile and has beta coefficient of 0.20. Track MEDIGEN VACCINE BIOLOGICS CORPORATE stock price on the chart and check out the list of the most volatile stocks — is MEDIGEN VACCINE BIOLOGICS CORPORATE there?
Today MEDIGEN VACCINE BIOLOGICS CORPORATE has the market capitalization of 11.55 B, it has decreased by −4.75% over the last week.
Yes, you can track MEDIGEN VACCINE BIOLOGICS CORPORATE financials in yearly and quarterly reports right on TradingView.
MEDIGEN VACCINE BIOLOGICS CORPORATE is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
MEDIGEN VACCINE BIOLOGICS CORPORATE revenue for the last quarter amounts to 243.00 M TWD, despite the estimated figure of 68.00 M TWD. In the next quarter, revenue is expected to reach 178.00 M TWD.
6547 net income for the last quarter is 1.51 M TWD, while the quarter before that showed 13.56 M TWD of net income which accounts for −88.88% change. Track more MEDIGEN VACCINE BIOLOGICS CORPORATE financial stats to get the full picture.
No, 6547 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 134.00 employees. See our rating of the largest employees — is MEDIGEN VACCINE BIOLOGICS CORPORATE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIGEN VACCINE BIOLOGICS CORPORATE EBITDA is −511.46 M TWD, and current EBITDA margin is −277.87%. See more stats in MEDIGEN VACCINE BIOLOGICS CORPORATE financial statements.
Like other stocks, 6547 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIGEN VACCINE BIOLOGICS CORPORATE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIGEN VACCINE BIOLOGICS CORPORATE technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIGEN VACCINE BIOLOGICS CORPORATE stock shows the sell signal. See more of MEDIGEN VACCINE BIOLOGICS CORPORATE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.